Abiopharma

News list

Smith Ryan A 🟢 acquired 1.3K shares of CAMDEN NATIONAL CORP (CAC) at $50.67 Transaction Date: Apr 28, 2026 | Filing ID: 000009

Full text

News bot April 30, 2026, 8:48 p.m.
🔍 Smith Ryan A (Executive)

Company: CAMDEN NATIONAL CORP (CAC)

Report Date: 2026-04-28
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 1,281
Detailed Transactions and Holdings:
- Acquired 1,281 shares of Common Stock at $50.67 per share (Direct)
  Date: 2026-04-28 | Code: A | equity_swap_involved: 0 | shares_owned_after: 24,276.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Represents a grant of restricted stock awards under the issuer's 2022 Equity and Incentive Plan and Amendment that are scheduled to vest pro-rata over the next three years, subject to continued employment through the vesting date. Each restricted stock award represents the right to receive one share of common stock at vesting.
- F2: Includes 7,711 restricted stock units and restricted shares that are subject to vesting and forfeiture restrictions.